Cardiovascular mortality after bilateral oophorectomy: a prospective cohort study.


Journal

Menopause (New York, N.Y.)
ISSN: 1530-0374
Titre abrégé: Menopause
Pays: United States
ID NLM: 9433353

Informations de publication

Date de publication:
01 11 2021
Historique:
pubmed: 3 11 2021
medline: 1 2 2022
entrez: 2 11 2021
Statut: epublish

Résumé

Bilateral oophorectomy permanently reduces endogenous estrogen exposure and may increase cardiovascular mortality in women. This study aimed to investigate the association between bilateral oophorectomy and cardiovascular mortality and whether this association was conditional on hysterectomy or on the use of hormone therapy at the time of study entry. A prospective cohort study of 25,338 female nurses aged ≥ 45 years within the Danish Nurse Cohort. Nurses were enrolled in 1993 or 1999 and followed until death, emigration, or end of follow-up on December 31, 2018, whichever came first. Exposure was bilateral oophorectomy. Outcome was cardiovascular mortality. Associations were estimated using Poisson regression models with log person-years as the offset. A total of 2,040 (8.1%) participants underwent bilateral oophorectomy. During a mean follow-up of 21.2 (SD: 5.6) years, 772 (3.0%) nurses died from cardiovascular disease. In adjusted analyses, a 31% higher rate of cardiovascular mortality was observed after bilateral oophorectomy (aMRR 1.31; 95% CI, 0.88-1.96) compared with women who retained their ovaries. No evidence of effect modification by use of hormone therapy at baseline or by hysterectomy on the association between bilateral oophorectomy and cardiovascular mortality was observed. Bilateral oophorectomy may be associated with cardiovascular mortality in women, but the estimate was not statistically significant. Additionally, we were unable to make firm conclusions regarding the possible modifying role of hormone therapy and hysterectomy on this potential association. Additional studies are needed to replicate this work.

Identifiants

pubmed: 34726195
doi: 10.1097/GME.0000000000001873
pii: 00042192-202201000-00007
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

28-34

Informations de copyright

Copyright © 2021 by The North American Menopause Society.

Déclaration de conflit d'intérêts

Financial disclosure/conflicts of interest: None reported.

Références

World Health Organization. Cardiovascular diseases. World Health Organ n.d. Available at: https://www.who.int/westernpacific/health-topics/cardiovascular-diseases (accessed March 11, 2021).
Sundhedsdatastyrelsen. Rapport: Dødsårsagsregisteret 2019. Sundhedsdatastyrelsen, Analyse, Statistik og Økonomi; 2020.
Maas AHEM, Appelman YEA. Gender differences in coronary heart disease. Neth Heart J 2010; 18:598–602.
Rodgers JL, Jones J, Bolleddu SI, et al. Cardiovascular risks associated with gender and aging. J Cardiovasc Dev Dis 2019; 6:1–18.
Ossewaarde ME, Bots ML, Verbeek ALM, et al. Age at menopause, cause-specific mortality and total life expectancy. Epidemiology 2005; 16:556–562.
Shuster LT, Gostout BS, Grossardt BR, Rocca WA. Prophylactic oophorectomy in pre-menopausal women and long term health – a review. Menopause Int 2008; 14:111–116.
Sarrel PM, Sullivan SD, Nelson LM. Hormone replacement therapy in young women with surgical primary ovarian insufficiency. Fertil Steril 2016; 106:1580–1587.
Faubion SS, Kuhle CL, Shuster LT, Rocca WA. Long-term health consequences of premature or early menopause and considerations for management. Climacteric 2015; 18:483–491.
Evans EC, Matteson KA, Orejuela FJ, et al. Salpingo-oophorectomy at the time of benign hysterectomy: a systematic review. Obstet Gynecol 2016; 128:476–485.
Tuesley KM, Protani MM, Webb PM, et al. Hysterectomy with and without oophorectomy and all-cause and cause-specific mortality. Am J Obstet Gynecol 2020; 223:1–16.
Rivera CM, Grossardt BR, Rhodes DJ, et al. Increased cardiovascular mortality following early bilateral oophorectomy. Menopause 2009; 16:15–23.
Gierach GL, Pfeiffer RM, Patel DA, et al. Long-term overall and disease-specific mortality associated with benign gynecologic surgery performed at different ages. Menopause 2014; 21:592–601.
Parker WH, Feskanich D, Broder MS, et al. Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses’ health study. Obstet Gynecol 2013; 121:709–716.
Chen L, Mishra GD, Dobson AJ, Wilson LF, Jones MA. Protective effect of hormone therapy among women with hysterectomy/oophorectomy. Hum Reprod 2017; 32:1–8.
Laughlin GA, Barrett-Connor E, Kritz-Silverstein D. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab 2000; 85:7.
Laughlin-Tommaso SK, Khan Z, Weaver AL, Smith CY, Rocca WA, Stewart EA. Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study. Menopause 2018; 25:483–492.
Matthews KA, Gibson CJ, EI Khoudary SR, Thurston RC. Changes in cardiovascular risk factors by hysterectomy status with and without oophorectomy: study of women's health across the nation. J Am Coll Cardiol 2013; 62:191–200.
Hundrup YA, Simonsen MK, Jorgensen T, Obel EB. Cohort profile: the Danish Nurse Cohort. Int J Epidemiol 2012; 41:1241–1247.
Pedersen CB. The Danish Civil Registration System. Scand J Public Health 2011; 39:22–25.
Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011; 39:30–33.
Helweg-Larsen K. The Danish Register of Causes of Death. Scand J Public Health 2011; 39:26–29.
Sundhedsdatastyrelsen. Dødsårsagsregisteret (DAR). Sundhedsdatastyrelsen 2020. Available at: https://sundhedsdatastyrelsen.dk/dar (accessed February 22, 2021).
Textor J, van der Zander B, Gilthorpe MS, Liśkiewicz M, Ellison GT. Robust causal inference using directed acyclic graphs: the R package ‘dagitty.’. Int J Epidemiol 2016; 45:1887–1894.
Polotsky H, Polotsky A. Metabolic implications of menopause. Semin Reprod Med 2010; 28:426–434.
Løkkegaard EL, Johnsen SP, Heitmann BL, et al. The validity of self-reported use of hormone replacement therapy among Danish nurses. Acta Obstet Gynecol Scand 2004; 83:476–481.
Wallach Kildemoes H, Toft Sørensen H, Hallas J. The Danish National Prescription Registry. Scand J Public Health 2011; 39:38–41.

Auteurs

Cathrine S Olesen (CS)

Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Denmark.
The International Research and Research Training Centre in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Trine Koch (T)

Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Denmark.
The International Research and Research Training Centre in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Cecilie S Uldbjerg (CS)

Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Denmark.
The International Research and Research Training Centre in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Laura S Gregersen (LS)

Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Denmark.
The International Research and Research Training Centre in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Jane Christensen (J)

Statistics and Data Analysis, Danish Cancer Society, Copenhagen, Denmark.

Christian Dehlendorff (C)

Statistics and Data Analysis, Danish Cancer Society, Copenhagen, Denmark.

Lærke Priskorn (L)

Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Denmark.
The International Research and Research Training Centre in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Louise F Wilson (LF)

The University of Queensland, NHMRC Centre for Research Excellence on Women and Non-communicable Diseases (CREWaND), School of Public Health, Herston Road, Herston, Queensland, Australia.

Youn-Hee Lim (YH)

Section of Environmental Health, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Seoul National University Medical Research Center, Seoul, Republic of Korea.

Jeanette T Jørgensen (JT)

Section of Environmental Health, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Zorana J Andersen (ZJ)

Section of Environmental Health, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Anders Juul (A)

Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Denmark.
The International Research and Research Training Centre in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Julie Abildgaard (J)

Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Denmark.
The International Research and Research Training Centre in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Centre for Physical Activity Research, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Martha Hickey (M)

Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Victoria, Australia.

Elvira V Bräuner (EV)

Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Denmark.
The International Research and Research Training Centre in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH